Effectiveness of second-line anti-HER2 treatment in HER2-positive metastatic breast cancer patients

• 作 者: Wei Zhao Li Bian Tao Wang Shao
• 机 构: DepartmentofBreastOncology,DepartmentofBreastOncology,PLARocketForceCharacteristicMedicalCenter
• 出 处: 中国癌症研究:英文版
• 发表日期: 2020年3期
• 关键词: Metastatic breast cancer trastuzumab failure SECOND-LINE real-world study
• 基金项目: Capital Clinical Medicine Special Project(No.Z181100001718215),National Natural Science Foundation of China(No.81602314).Research number:CSCO-BC RWS 16002

Objective:Several studies have demonstrated different benefits for patients whose disease progressed despite previous trastuzumab treatment.Due to limited real-world data,we evaluate the effectiveness of anti-human epidermal growth factor receptor 2(HER2)